×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
|
Dashboard
Analyses
Exchange
Gaps
←
Home
/
Wiki
/
Therapeutic: nadph-oxidase-inhibitors
therapeutic
1,497 words
KG: NADPH
Contents
nadph-oxidase-inhibitors
💊
Therapeutic Info
Name
NADPH
Key Genes/Proteins
ACTB
,
AMBRA1
,
AMPK
,
ATG5
,
ATP
,
BAK1
Related Diseases
ALS
Related Pathways
apoptosis pathway
,
autophagy pathway
No AI portrait yet
Generate portrait ✦
Knowledge Graph
Related Hypotheses (17)
Microbial Inflammasome Priming Prevention
Score: 0.65
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.73
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.91
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.79
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.74
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.73
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.71
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.71
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.70
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.65
Synthetic Biology Rewiring via Orthogonal Receptors
Score: 0.65
Vagal Afferent Microbial Signal Modulation
Score: 0.62
Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro
Score: 0.61
Tau-Independent Microtubule Stabilization via MAP6 Enhanceme
Score: 0.57
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.48
Show 12 more
Related Analyses (15)
Astrocyte Reactivity Subtypes in Neurodegeneration
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · completed
Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Show 10 more
Related Experiments (25)
Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40
Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40
Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40
Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.40
Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Gandouling protection against brain injury in Wilson's disea
validation · proposed · Score: 0.90
MAP6 depletion effects on neuronal development in primary cu
exploratory · proposed · Score: 0.90
S-equol-induced ferroptosis mechanism in TNBC cells
exploratory · proposed · Score: 0.90
TLR expression analysis in Parkinson's disease patients
clinical · proposed · Score: 0.85
TLR4 Activation Assay with NETs and Anti-CarP Antibodies
exploratory · proposed · Score: 0.85
TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80
Axonal Transport Dysfunction Validation in Parkinson's Disea
clinical · proposed · Score: 0.40
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Prion Strain Diversity and Selective Vulnerability
clinical · proposed · Score: 0.40
Peroxisome Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Show 20 more
See Also (12)
Autophagy Enhancement Drug Screening for Neurodegenerat
experiment · KG edge: activates
BCL2 Gene
gene · KG edge: activates
BECN1 Gene
gene · KG edge: activates
chop
gene · KG edge: activates
FIS1 Gene
gene · KG edge: activates
GPX4 Gene - Glutathione Peroxidase 4
gene · KG edge: inhibits
IDH1 Gene - Isocitrate Dehydrogenase 1
gene · KG edge: associated_with
idh2
gene · KG edge: activates
MLCK Gene
gene · KG edge: activates
MYD88 Gene
gene · KG edge: activates
CREB-independent Neuronal Survival Pathways
mechanism · KG edge: activates
Catalase Protein
redirect · KG edge: associated_with
Show 7 more
Knowledge Graph (12 edges)
NRF2
regulates
NADPH
NADPH
inhibits
p38
NADPH
treats
Glaucoma
NADPH
activates
PUMA
NADPH
activates
FIS1
NADPH
activates
BECLIN1
NADPH
activates
HO-1
NADPH
activates
inflammation
NADPH
activates
apoptosis
NADPH
activates
oxidative stress
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)